Cas12a 基础组合敲除筛查定义 DNA 损伤反应的遗传架构
Cas12a-based combinatorial knockout screens define the genetic architecture of the DNA damage response
Esmaeili Anvar 等人利用 Cas12a 技术进行组合敲除筛查,揭示了 DNA 损伤反应的遗传架构。研究结果为理解细胞功能和基因互作提供了新见解。
Hoeijmakers, J. H. J. DNA damage, aging, and cancer. N. Engl. J. Med. 361, 1475–1485 https://doi.org/10.1056/NEJMra0804615 (2009).
Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179–204 https://doi.org/10.1016/j.molcel.2010.09.019 (2010).
Costanzo, M. et al. The genetic landscape of a cell. Science 327, 425–431 https://doi.org/10.1126/science.1180823 (2010).
Costanzo, M. et al. A global genetic interaction network maps a wiring diagram of cellular function. Science 353, aaf1420 https://doi.org/10.1126/science.aaf1420 (2016).
Tong, A. H. Y. et al. Global mapping of the yeast genetic interaction network. Science 303, 808–813 https://doi.org/10.1126/science.1091317 (2004).
Billmann, M. et al. Global genetic interaction network of a human cell maps conserved principles and informs functional interpretation of gene co-essentiality profiles. Cell 189, 3736–3759 https://doi.org/10.1016/j.cell.2026.03.044 (2026).
Horlbeck, M. A. et al. Mapping the genetic landscape of human cells. Cell 174, 953–967 https://doi.org/10.1016/j.cell.2018.06.010 (2018).
Domingo, J., Baeza-Centurion, P. & Lehner, B. The causes and consequences of genetic interactions (epistasis). Annu. Rev. Genomics Hum. Genet. 20, 433–460 https://doi.org/10.1146/annurev-genom-083118-014857 (2019).
Costanzo, M., Baryshnikova, A., Myers, C. L., Andrews, B. & Boone, C. Charting the genetic interaction map of a cell. Curr. Opin. Biotechnol. 22, 66–74 https://doi.org/10.1016/j.copbio.2010.11.001 (2011).
Costanzo, M. et al. Global genetic networks and the genotype-to-phenotype relationship. Cell 177, 85–100 https://doi.org/10.1016/j.cell.2019.01.033 (2019).
Beijersbergen, R. L., Wessels, L. F. A. & Bernards, R. Synthetic lethality in cancer therapeutics. Annu. Rev. Cancer Biol. 1, 141–161 https://doi.org/10.1146/annurev-cancerbio-042016-073434 (2017).
Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR–Cas system. Cell 163, 759–771 https://doi.org/10.1016/j.cell.2015.09.038 (2015).
Hegde, M., Strand, C., Hanna, R. E. & Doench, J. G. Uncoupling of sgRNAs from their associated barcodes during PCR amplification of combinatorial CRISPR screens. PLoS ONE 13, e0197547 https://doi.org/10.1371/journal.pone.0197547 (2018).
Najm, F. J. et al. Orthologous CRISPR–Cas9 enzymes for combinatorial genetic screens. Nat. Biotechnol. 36, 179–189 https://doi.org/10.1038/nbt.4048 (2018).
Shen, J. P. et al. Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactions. Nat. Methods 14, 573–576 https://doi.org/10.1038/nmeth.4225 (2017).
Esmaeili Anvar, N. et al. Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform. Nat. Commun. 15, 3577 https://doi.org/10.1038/s41467-024-47795-3 (2024).
Parrish, P. C. R. et al. Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome. Cell Rep. 36, 109597 https://doi.org/10.1016/j.celrep.2021.109597 (2021).
Dede, M., McLaughlin, M., Kim, E. & Hart, T. Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome Biol. 21, 262 https://doi.org/10.1186/s13059-020-02173-2 (2020).
Gonatopoulos-Pournatzis, T. et al. Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform. Nat. Biotechnol. 38, 638–648 https://doi.org/10.1038/s41587-020-0437-z (2020).
Ito, T. et al. Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nat. Genet. 53, 1664–1672 https://doi.org/10.1038/s41588-021-00967-z (2021).
Thompson, N. A. et al. Combinatorial CRISPR screen identifies fitness effects of gene paralogues. Nat. Commun. 12, 1302 https://doi.org/10.1038/s41467-021-21478-9 (2021).
DeWeirdt, P. C. et al. Optimization of AsCas12a for combinatorial genetic screens in human cells. Nat. Biotechnol. 39, 94–104 https://doi.org/10.1038/s41587-020-0600-6 (2021).
Kleinstiver, B. P. et al. Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276–282 https://doi.org/10.1038/s41587-018-0011-0 (2019).
Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075–6086 (1990).
Puleo, J. & Polyak, K. The MCF10 model of breast tumor progression. Cancer Res. 81, 4183–4185 https://doi.org/10.1158/0008-5472.CAN-21-1939 (2021).
Yoon, D.-S. et al. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am. J. Pathol. 161, 391–397 https://doi.org/10.1016/S0002-9440(10)64194-6 (2002).
Volpe, E. et al. The reference genome of the human diploid cell line RPE-1. Nat. Commun. 16, 7751 https://doi.org/10.1038/s41467-025-62428-z (2025).
Noordermeer, S. M. et al. The shieldin complex mediates 53BP1-dependent DNA repair. Nature 560, 117–121 https://doi.org/10.1038/s41586-018-0340-7 (2018).
Feng, W. & Jasin, M. BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination. Nat. Commun. 8, 525 https://doi.org/10.1038/s41467-017-00634-0 (2017).
Zhou, J. et al. A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors. Nat. Cancer 2, 598–610 https://doi.org/10.1038/s43018-021-00203-x (2021).
Hernando, B. et al. Tracking ongoing chromosomal instability using single-cell whole-genome sequencing. Preprint at bioRxiv https://doi.org/10.1101/2025.11.26.690781 (2025).
Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564–576 https://doi.org/10.1016/j.cell.2017.06.010 (2017).
Mani, R., St.Onge, R. P., Hartman, J. L., Giaever, G. & Roth, F. P. Defining genetic interaction. Proc. Natl Acad. Sci. USA 105, 3461–3466 https://doi.org/10.1073/pnas.0712255105 (2008).
Elena, S. F. & Lenski, R. E. Test of synergistic interactions among deleterious mutations in bacteria. Nature 390, 395–398 https://doi.org/10.1038/37108 (1997).
Chou, J., Lin, C., Kim, S., Chen, J. & Hart, T. Analysis of combinatorial knockout CRISPR screens with GRAPE: genetic interaction regression analysis of pairwise effects. Preprint at bioRxiv https://doi.org/10.64898/2026.02.09.704894 (2026).
Cao, L. et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol. Cell 35, 534–541 https://doi.org/10.1016/j.molcel.2009.06.037 (2009).
Bunting, S. F. et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141, 243–254 https://doi.org/10.1016/j.cell.2010.03.012 (2010).
Bouwman, P. et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17, 688–695 https://doi.org/10.1038/nsmb.1831 (2010).
Garner, E., Kim, Y., Lach, F. P., Kottemann, M. C. & Smogorzewska, A. Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctions. Cell Rep. 5, 207–215 https://doi.org/10.1016/j.celrep.2013.08.041 (2013).
Sarbajna, S., Davies, D. & West, S. C. Roles of SLX1–SLX4, MUS81–EME1, and GEN1 in avoiding genome instability and mitotic catastrophe. Genes Dev. 28, 1124–1136 https://doi.org/10.1101/gad.238303.114 (2014).
Hustedt, N. et al. Control of homologous recombination by the HROB–MCM8–MCM9 pathway. Genes Dev 33, 1397–1415 https://doi.org/10.1101/gad.329508.119 (2019).
Alvarez-Quilon, A. et al. Endogenous DNA 3′ blocks are vulnerabilities for BRCA1 and BRCA2 deficiency and are reversed by the APE2 nuclease. Mol. Cell 78, 1152–1165 https://doi.org/10.1016/j.molcel.2020.05.021 (2020).
AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discov. 7, 818–831 https://doi.org/10.1158/2159-8290.CD-17-0151 (2017).
Sultana, R. et al. Targeting XRCC1 deficiency in breast cancer for personalized therapy. Cancer Res. 73, 1621–1634 https://doi.org/10.1158/0008-5472.CAN-12-2929 (2013).
Ali, R. et al. XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib. Ther. Adv. Med. Oncol. 12, 1758835920974201 https://doi.org/10.1177/1758835920974201 (2020).
Riabinska, A. et al. Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors. Sci. Transl. Med. 5, 189ra178 https://doi.org/10.1126/scitranslmed.3005814 (2013).
Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980–D985 https://doi.org/10.1093/nar/gkt1113 (2014).
Prakash, R. et al. Distinct pathways of homologous recombination controlled by the SWS1–SWSAP1–SPIDR complex. Nat. Commun. 12, 4255 https://doi.org/10.1038/s41467-021-24205-6 (2021).
Tummala, H. et al. ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function. Am. J. Hum. Genet. 94, 246–256 https://doi.org/10.1016/j.ajhg.2014.01.007 (2014).
Yin, Y. et al. Phase separation of ERCC6L2–CtIP regulates the extent of DNA end resection. Nat. Cell Biol. 27, 1771–1784 https://doi.org/10.1038/s41556-025-01760-4 (2025).
Touzot, F. et al. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal–Hreidarsson syndrome. Proc. Natl Acad. Sci. USA 107, 10097–10102 https://doi.org/10.1073/pnas.0914918107 (2010).
Akhter, S., Lam, Y. C., Chang, S. & Legerski, R. J. The telomeric protein SNM1B/Apollo is required for normal cell proliferation and embryonic development. Aging Cell 9, 1047–1056 https://doi.org/10.1111/j.1474-9726.2010.00631.x (2010).
Olivieri, M. et al. A genetic map of the response to DNA damage in human cells. Cell 182, 481–496 https://doi.org/10.1016/j.cell.2020.05.040 (2020).
Joshua, M. D. et al. Extracting biological insights from the Project Achilles genome-scale CRISPR screens in cancer cell lines. Preprint at bioRxiv https://doi.org/10.1101/720243 (2019).
Pan, J. et al. Interrogation of mammalian protein complex structure, function, and membership using genome-scale fitness screens. Cell Syst. 6, 555–568 https://doi.org/10.1016/j.cels.2018.04.011 (2018).
Meldal, B. H. M. et al. Complex Portal 2018: extended content and enhanced visualization tools for macromolecular complexes. Nucleic Acids Res. 47, D550–D558 https://doi.org/10.1093/nar/gky1001 (2019).
Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779–1784 https://doi.org/10.1038/ng.3984 (2017).
Behan, F. M. et al. Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens. Nature 568, 511–516 https://doi.org/10.1038/s41586-019-1103-9 (2019).
Segrè, D., DeLuna, A., Church, G. M. & Kishony, R. Modular epistasis in yeast metabolism. Nat. Genet. 37, 77–83 https://doi.org/10.1038/ng1489 (2005).
Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913–917 (2005).
Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005).
Panday, A. et al. FANCM regulates repair pathway choice at stalled replication forks. Mol. Cell 81, 2428–2444 https://doi.org/10.1016/j.molcel.2021.03.044 (2021).
Dev, H. et al. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. Nat. Cell Biol. 20, 954–965 https://doi.org/10.1038/s41556-018-0140-1 (2018).
Ghezraoui, H. et al. 53BP1 cooperation with the REV7–shieldin complex underpins DNA structure-specific NHEJ. Nature 560, 122–127 https://doi.org/10.1038/s41586-018-0362-1 (2018).
Gupta, R. et al. DNA repair network analysis reveals shieldin as a key regulator of NHEJ and PARP inhibitor sensitivity. Cell 173, 972–988 https://doi.org/10.1016/j.cell.2018.03.050 (2018).
Mirman, Z. et al. 53BP1–RIF1–shieldin counteracts DSB resection through CST- and Polα-dependent fill-in. Nature 560, 112–116 https://doi.org/10.1038/s41586-018-0324-7 (2018).
Fielden, J. et al. Comprehensive interrogation of synthetic lethality in the DNA damage response. Nature 640, 1093–1102 https://doi.org/10.1038/s41586-025-08815-4 (2025).
Feng, S. et al. Profound synthetic lethality between SMARCAL1 and FANCM. Mol. Cell 84, 4522–4537 https://doi.org/10.1016/j.molcel.2024.10.016 (2024).
Shor, E., Weinstein, J. & Rothstein, R. A genetic screen for top3 suppressors in Saccharomyces cerevisiae identifies SHU1, SHU2, PSY3 and CSM2: four genes involved in error-free DNA repair. Genetics 169, 1275–1289 https://doi.org/10.1534/genetics.104.036764 (2005).
Burgers, P. M. J. & Kunkel, T. A. Eukaryotic DNA replication fork. Annu. Rev. Biochem. 86, 417–438 https://doi.org/10.1146/annurev-biochem-061516-044709 (2017).
da Costa, A. A. et al. Single-stranded DNA gap accumulation is a functional biomarker for USP1 inhibitor sensitivity. Cancer Res. 84, 3435–3446 https://doi.org/10.1158/0008-5472.CAN-23-4007 (2024).
Huang, T. T. et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8, 339–347 https://doi.org/10.1038/ncb1378 (2006).
Garcia-Rodriguez, N., Wong, R. P. & Ulrich, H. D. Functions of ubiquitin and SUMO in DNA replication and replication stress. Front. Genet. 7, 87 https://doi.org/10.3389/fgene.2016.00087 (2016).
Bellelli, R. et al. Polε instability drives replication stress, abnormal development, and tumorigenesis. Mol. Cell 70, 707–721 https://doi.org/10.1016/j.molcel.2018.04.008 (2018).
Bass, T. E. et al. ETAA1 acts at stalled replication forks to maintain genome integrity. Nat. Cell Biol. 18, 1185–1195 https://doi.org/10.1038/ncb3415 (2016).
Haahr, P. et al. Activation of the ATR kinase by the RPA-binding protein ETAA1. Nat. Cell Biol. 18, 1196–1207 https://doi.org/10.1038/ncb3422 (2016).
Higgs, M. R. et al. BOD1L is required to suppress deleterious resection of stressed replication forks. Mol. Cell 59, 462–477 https://doi.org/10.1016/j.molcel.2015.06.007 (2015).
Parrilla-Castellar, E. R., Arlander, S. J. & Karnitz, L. Dial 9-1-1 for DNA damage: the Rad9–Hus1–Rad1 (9-1-1) clamp complex. DNA Repair (Amst.) 3, 1009–1014 https://doi.org/10.1016/j.dnarep.2004.03.032 (2004).
Balmus, G. et al. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1. Hum. Mol. Genet. 21, 3408–3420 https://doi.org/10.1093/hmg/dds173 (2012).
Shen, J. P. et al. Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition. Oncotarget 6, 35755–35769 https://doi.org/10.18632/oncotarget.5928 (2015).
Lin, K. et al. A scalable platform for efficient CRISPR–Cas9 chemical–genetic screens of DNA damage-inducing compounds. Sci. Rep. 14, 2508 https://doi.org/10.1038/s41598-024-51735-y (2024).
Koppensteiner, R. et al. Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro. PLoS ONE 9, e100041 https://doi.org/10.1371/journal.pone.0100041 (2014).
Dumoulin, I. et al. PARG inhibition sequesters nuclear PAR-binding proteins, including XRCC1 and its partners, into nuclear condensates to elicit cytotoxicity. Preprint at bioRxiv https://doi.org/10.64898/2026.03.18.712393 (2026).
Nie, L. et al. DePARylation is critical for S phase progression and cell survival. eLife 12, RP89303 https://doi.org/10.7554/eLife.89303 (2024).
Huang, J. W. et al. MCM8IP activates the MCM8–9 helicase to promote DNA synthesis and homologous recombination upon DNA damage. Nat. Commun. 11, 2948 https://doi.org/10.1038/s41467-020-16718-3 (2020).
Griffin, W. C. et al. A multi-functional role for the MCM8/9 helicase complex in maintaining fork integrity during replication stress. Nat. Commun. 13, 5090 https://doi.org/10.1038/s41467-022-32583-8 (2022).
Gan, G. N., Wittschieben, J. P., Wittschieben, B. Ø & Wood, R. D. DNA polymerase zeta (Pol ζ) in higher eukaryotes. Cell Res. 18, 174–183 https://doi.org/10.1038/cr.2007.117 (2008).
Harrigan, J. A. et al. Replication stress induces 53BP1-containing OPT domains in G1 cells. J. Cell Biol. 193, 97–108 https://doi.org/10.1083/jcb.201011083 (2011).
Lukas, C. et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat. Cell Biol. 13, 243–253 https://doi.org/10.1038/ncb2201 (2011).
Findlay, S. et al. SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. EMBO J. 37, e100158 https://doi.org/10.15252/embj.2018100158 (2018).
Tomida, J. et al. FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells. EMBO J. 37, e99543 https://doi.org/10.15252/embj.201899543 (2018).
Hara, K. et al. Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1. J. Biol. Chem. 285, 12299–12307 https://doi.org/10.1074/jbc.M109.092403 (2010).
Liang, L. et al. Molecular basis for assembly of the shieldin complex and its implications for NHEJ. Nat. Commun. 11, 1972 https://doi.org/10.1038/s41467-020-15879-5 (2020).
Wojtaszek, J. L. et al. A small molecule targeting mutagenic translesion synthesis improves chemotherapy. Cell 178, 152–159 https://doi.org/10.1016/j.cell.2019.05.028 (2019).
Taglialatela, A. et al. REV1–Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Mol. Cell 81, 4008–4025 https://doi.org/10.1016/j.molcel.2021.08.016 (2021).
Tirman, S. et al. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells. Mol. Cell 81, 4026–4040 https://doi.org/10.1016/j.molcel.2021.09.013 (2021).
Jiang, Y. K., Medley, E. A. & Brown, G. W. Two independent DNA repair pathways cause mutagenesis in template switching deficient Saccharomyces cerevisiae. Genetics 225, iyad153 https://doi.org/10.1093/genetics/iyad153 (2023).
Mann, A. et al. POLθ prevents MRE11–NBS1–CtIP-dependent fork breakage in the absence of BRCA2/RAD51 by filling lagging-strand gaps. Mol. Cell 82, 4218–4231 https://doi.org/10.1016/j.molcel.2022.09.013 (2022).
Hanthi, Y. W. et al. RAD51 protects abasic sites to prevent replication fork breakage. Mol. Cell 84, 3026–3043 https://doi.org/10.1016/j.molcel.2024.07.004 (2024).
Chan, Y. W., Fugger, K. & West, S. C. Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations. Nat. Cell Biol. 20, 92–103 https://doi.org/10.1038/s41556-017-0011-1 (2018).
Chan, Y. W. & West, S. C. Spatial control of the GEN1 Holliday junction resolvase ensures genome stability. Nat. Commun. 5, 4844 https://doi.org/10.1038/ncomms5844 (2014).
Adam, S. et al. The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer. Nat. Cancer 2, 1357–1371 https://doi.org/10.1038/s43018-021-00266-w (2021).
De Marco Zompit, M. et al. The CIP2A–TOPBP1 complex safeguards chromosomal stability during mitosis. Nat. Commun. 13, 4143 https://doi.org/10.1038/s41467-022-31865-5 (2022).
Brambati, A. et al. RHINO directs MMEJ to repair DNA breaks in mitosis. Science 381, 653–660 https://doi.org/10.1126/science.adh3694 (2023).
Lin, Y.-F. et al. Mitotic clustering of pulverized chromosomes from micronuclei. Nature 618, 1041–1048 https://doi.org/10.1038/s41586-023-05974-0 (2023).
Cotta-Ramusino, C. et al. A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. Science 332, 1313–1317 https://doi.org/10.1126/science.1203430 (2011).
Ip, S. C. Y. et al. Identification of Holliday junction resolvases from humans and yeast. Nature 456, 357–361 https://doi.org/10.1038/nature07470 (2008).
Benitez, A. et al. GEN1 promotes common fragile site expression. Cell Rep. 42, 112062 https://doi.org/10.1016/j.celrep.2023.112062 (2023).
Niraj, J., Farkkila, A. & D’Andrea, A. D. The Fanconi anemia pathway in cancer. Annu. Rev. Cancer Biol. 3, 457–478 https://doi.org/10.1146/annurev-cancerbio-030617-050422 (2019).
Fleury, H. et al. The APE2 nuclease is essential for DNA double-strand break repair by microhomology-mediated end joining. Mol. Cell 83, 1429–1445 https://doi.org/10.1016/j.molcel.2023.03.017 (2023).
Mateos-Gomez, P. A. et al. Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination. Nature 518, 254–257 https://doi.org/10.1038/nature14157 (2015).
Ceccaldi, R. et al. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair. Nature 518, 258–262 https://doi.org/10.1038/nature14184 (2015).
Mengwasser, K. E. et al. Genetic screens reveal FEN1 and APEX2 as BRCA2 synthetic lethal targets. Mol. Cell 73, 885–899 https://doi.org/10.1016/j.molcel.2018.12.008 (2019).
Gelot, C. et al. Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis. Nature 621, 415–422 https://doi.org/10.1038/s41586-023-06506-6 (2023).
van Zeeburg, H. J. et al. Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients. Cancer Res. 65, 1271–1276 https://doi.org/10.1158/0008-5472.CAN-04-3665 (2005).
Nguyen, H. T. et al. Fanconi anemia–isogenic head and neck cancer cell line pairs: a basic and translational science resource. Int. J. Cancer 153, 183–196 https://doi.org/10.1002/ijc.34506 (2023).
Bansbach, C. E., Betous, R., Lovejoy, C. A., Glick, G. G. & Cortez, D. The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. Genes Dev. 23, 2405–2414 https://doi.org/10.1101/gad.1839909 (2009).
Ciccia, A. et al. The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. Genes Dev. 23, 2415–2425 https://doi.org/10.1101/gad.1832309 (2009).
Postow, L., Woo, E. M., Chait, B. T. & Funabiki, H. Identification of SMARCAL1 as a component of the DNA damage response. J. Biol. Chem. 284, 35951–35961 https://doi.org/10.1074/jbc.M109.048330 (2009).
Betous, R. et al. SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. Genes Dev. 26, 151–162 https://doi.org/10.1101/gad.178459.111 (2012).
Ciccia, A. et al. Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress. Mol. Cell 47, 396–409 https://doi.org/10.1016/j.molcel.2012.05.024 (2012).
Yuan, J., Ghosal, G. & Chen, J. The annealing helicase HARP protects stalled replication forks. Genes Dev. 23, 2394–2399 https://doi.org/10.1101/gad.1836409 (2009).
Yusufzai, T., Kong, X., Yokomori, K. & Kadonaga, J. T. The annealing helicase HARP is recruited to DNA repair sites via an interaction with RPA. Genes Dev. 23, 2400–2404 https://doi.org/10.1101/gad.1831509 (2009).
Gari, K., Decaillet, C., Delannoy, M., Wu, L. & Constantinou, A. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl Acad. Sci. USA 105, 16107–16112 https://doi.org/10.1073/pnas.0804777105 (2008).
Yan, Z. et al. A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol. Cell 37, 865–878 https://doi.org/10.1016/j.molcel.2010.01.039 (2010).
Abbouche, L., Bythell-Douglas, R. & Deans, A. J. FANCM branchpoint translocase: master of traverse, reverse and adverse DNA repair. DNA Repair (Amst.) 140, 103701 https://doi.org/10.1016/j.dnarep.2024.103701 (2024).
Singh, T. R. et al. MHF1–MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol. Cell 37, 879–886 https://doi.org/10.1016/j.molcel.2010.01.036 (2010).
Ciccia, A. et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25, 331–343 https://doi.org/10.1016/j.molcel.2007.01.003 (2007).
Canela, A. et al. DNA breaks and end resection measured genome-wide by end sequencing. Mol. Cell 63, 898–911 https://doi.org/10.1016/j.molcel.2016.06.034 (2016).
Stoepker, C. et al. Defects in the Fanconi anemia pathway and chromatid cohesion in head and neck cancer. Cancer Res. 75, 3543–3553 https://doi.org/10.1158/0008-5472.CAN-15-0528 (2015).
Meetei, A. R. et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37, 958–963 (2005).
Schmiester, M. & Demuth, I. SNM1B/Apollo in the DNA damage response and telomere maintenance. Oncotarget 8, 48398–48409 https://doi.org/10.18632/oncotarget.16864 (2017).
Demuth, I., Digweed, M. & Concannon, P. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogene 23, 8611–8618 https://doi.org/10.1038/sj.onc.1207895 (2004).
Mason, J. M. et al. The SNM1B/APOLLO DNA nuclease functions in resolution of replication stress and maintenance of common fragile site stability. Hum. Mol. Genet. 22, 4901–4913 https://doi.org/10.1093/hmg/ddt340 (2013).
Bae, J. B. et al. Snm1B/Apollo mediates replication fork collapse and S phase checkpoint activation in response to DNA interstrand cross-links. Oncogene 27, 5045–5056 https://doi.org/10.1038/onc.2008.139 (2008).
Liu, L. et al. SNM1B/Apollo interacts with astrin and is required for the prophase cell cycle checkpoint. Cell Cycle 8, 628–638 https://doi.org/10.4161/cc.8.4.7791 (2009).
Wu, P., van Overbeek, M., Rooney, S. & de Lange, T. Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol. Cell 39, 606–617 https://doi.org/10.1016/j.molcel.2010.06.031 (2010).
van Overbeek, M. & de Lange, T. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr. Biol. 16, 1295–1302 https://doi.org/10.1016/j.cub.2006.05.022 (2006).
Lam, Y. C. et al. SNM1B/Apollo protects leading-strand telomeres against NHEJ-mediated repair. EMBO J. 29, 2230–2241 https://doi.org/10.1038/emboj.2010.58 (2010).
Myler, L. R. et al. DNA-PK and the TRF2 iDDR inhibit MRN-initiated resection at leading-end telomeres. Nat. Struct. Mol. Biol. 30, 1346–1356 https://doi.org/10.1038/s41594-023-01072-x (2023).
Eickhoff, P. et al. Chromosome end protection by RAP1-mediated inhibition of DNA-PK. Nature 642, 1090–1096 https://doi.org/10.1038/s41586-025-08896-1 (2025).
Chen, Y. et al. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 319, 1092–1096 https://doi.org/10.1126/science.1151804 (2008).
Du, D. et al. Genetic interaction mapping in mammalian cells using CRISPR interference. Nat. Methods 14, 577–580 https://doi.org/10.1038/nmeth.4286 (2017).
Simpson, D., Ling, J., Jing, Y. & Adamson, B. Mapping the genetic interaction network of PARP inhibitor response. Preprint at bioRxiv https://doi.org/10.1101/2023.08.19.553986 (2023).
Norman, T. M. et al. Exploring genetic interaction manifolds constructed from rich single-cell phenotypes. Science 365, 786–793 https://doi.org/10.1126/science.aax4438 (2019).
Herken, B. W. et al. Large-scale mapping of environmental-genetic interactions illustrates the dynamic nature of cell-cycle and DNA repair regulation. Mol. Cell 86, 757–773 https://doi.org/10.1016/j.molcel.2026.01.025 (2026).
Tang, A., Ardy, R. C., Mendes, R. E. & Norman, T. M. Scaling perturbations: beyond genome-scale CRISPR screens. Preprint at bioRxiv https://doi.org/10.64898/2026.01.16.699948 (2026).
Sanson, K. R. et al. Optimized libraries for CRISPR–Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 https://doi.org/10.1038/s41467-018-07901-8 (2018).
Seppa, I. M. et al. MRN–CtIP, EXO1, and DNA2–WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage. Genes Dev. 39, 582–602 https://doi.org/10.1101/gad.352421.124 (2025).
Dungrawala, H. et al. The replication checkpoint prevents two types of fork collapse without regulating replisome stability. Mol. Cell 59, 998–1010 https://doi.org/10.1016/j.molcel.2015.07.030 (2015).
Martin, S. K. & Wood, R. D. DNA polymerase ζ in DNA replication and repair. Nucleic Acids Res. 47, 8348–8361 https://doi.org/10.1093/nar/gkz705 (2019).
Chan, K. L. & Hickson, I. D. New insights into the formation and resolution of ultra-fine anaphase bridges. Semin. Cell Dev. Biol. 22, 906–912 https://doi.org/10.1016/j.semcdb.2011.07.001 (2011).
Martin, P. R. et al. The CIP2A–TOPBP1 axis facilitates mitotic DNA repair via MiDAS and MMEJ. Nat. Commun. 16, 10623 https://doi.org/10.1038/s41467-025-65594-2 (2025).
de Haan, L. et al. CIP2A mediates mitotic recruitment of SLX4/MUS81/XPF to resolve replication stress-induced DNA lesions. Nat. Commun. 17, 13 https://doi.org/10.1038/s41467-025-66549-3 (2025).
Bagge, J. et al. TopBP1 coordinates DNA repair synthesis in mitosis via recruitment of the nuclease scaffold SLX4. Commun. Biol. 8, 1005 https://doi.org/10.1038/s42003-025-08442-9 (2025).
Kim, Y. et al. Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet. 43, 142–146 https://doi.org/10.1038/ng.750 (2011).
Klein Douwel, D. et al. XPF–ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol. Cell 54, 460–471 https://doi.org/10.1016/j.molcel.2014.03.015 (2014).
Zhang, J. & Walter, J. C. Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair (Amst.) 19, 135–142 https://doi.org/10.1016/j.dnarep.2014.03.018 (2014).
Osman, F. & Whitby, M. C. Emerging roles for centromere-associated proteins in DNA repair and genetic recombination. Biochem. Soc. Trans. 41, 1726–1730 https://doi.org/10.1042/BST20130200 (2013).
Tao, Y. et al. The structure of the FANCM–MHF complex reveals physical features for functional assembly. Nat. Commun. 3, 782 https://doi.org/10.1038/ncomms1779 (2012).
Zafar, F. et al. Regulation of mitotic recombination between DNA repeats in centromeres. Nucleic Acids Res. 45, 11222–11235 https://doi.org/10.1093/nar/gkx763 (2017).
Cox, K. E., Marechal, A. & Flynn, R. L. SMARCAL1 resolves replication stress at ALT telomeres. Cell Rep. 14, 1032–1040 https://doi.org/10.1016/j.celrep.2016.01.011 (2016).
Silva, B. et al. FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops. Nat. Commun. 10, 2253 https://doi.org/10.1038/s41467-019-10179-z (2019).
Lu, R. et al. The FANCM–BLM–TOP3A–RMI complex suppresses alternative lengthening of telomeres (ALT). Nat. Commun. 10, 2252 https://doi.org/10.1038/s41467-019-10180-6 (2019).
Rivera, T., Haggblom, C., Cosconati, S. & Karlseder, J. A balance between elongation and trimming regulates telomere stability in stem cells. Nat. Struct. Mol. Biol. 24, 30–39 https://doi.org/10.1038/nsmb.3335 (2017).
Poole, L. A. et al. SMARCAL1 maintains telomere integrity during DNA replication. Proc. Natl Acad. Sci. USA 112, 14864–14869 https://doi.org/10.1073/pnas.1510750112 (2015).
Taglialatela, A. et al. SMARCAL1 is a candidate therapeutic target for ALT-positive tumors. Genes Dev. 40, 1283–1303 https://doi.org/10.1101/gad.353377.125 (2026).
Brickner, J. R., Garzon, J. L. & Cimprich, K. A. Walking a tightrope: the complex balancing act of R-loops in genome stability. Mol. Cell 82, 2267–2297 https://doi.org/10.1016/j.molcel.2022.04.014 (2022).
Carnie, C. J. et al. ERCC6L2 mitigates replication stress and promotes centromere stability. Cell Rep. 42, 112329 https://doi.org/10.1016/j.celrep.2023.112329 (2023).
Reichl, P. I. et al. The ERCC6L2–MRI–KU complex coordinates NHEJ at staggered DNA double-strand breaks. Preprint at bioRxiv https://doi.org/10.1101/2025.11.28.691009 (2025).
Goodman, M. F. & Woodgate, R. Translesion DNA polymerases. Cold Spring Harb. Perspect. Biol. 5, a010363 https://doi.org/10.1101/cshperspect.a010363 (2013).
Lenain, C. et al. The Apollo 5′ exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr. Biol. 16, 1303–1310 https://doi.org/10.1016/j.cub.2006.05.021 (2006).
Aird, E. J. et al. ERCC6L2 ensures repair fidelity for staggered-end DNA double-strand breaks. Nat. Commun. 17, 2743 https://doi.org/10.1038/s41467-026-69843-w (2026).
Han, J. et al. ATM controls the extent of DNA end resection by eliciting sequential posttranslational modifications of CtIP. Proc. Natl Acad. Sci. USA 118, e2022600118 https://doi.org/10.1073/pnas.2022600118 (2021).
Rabl, J. BRCA1-A and BRISC: multifunctional molecular machines for ubiquitin signaling. Biomolecules 10, 1503 https://doi.org/10.3390/biom10111503 (2020).
Hu, Y. et al. RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci. Genes Dev. 25, 685–700 https://doi.org/10.1101/gad.2011011 (2011).
Elango, R. et al. The structure-specific endonuclease complex SLX4–XPF regulates Tus–Ter-induced homologous recombination. Nat. Struct. Mol. Biol. 29, 801–812 https://doi.org/10.1038/s41594-022-00812-9 (2022).
Kiiski, J. I. et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc. Natl Acad. Sci. USA 111, 15172–15177 https://doi.org/10.1073/pnas.1407909111 (2014).
Lopes, J. L., Chaudhry, S., Lopes, G. S., Levin, N. K. & Tainsky, M. A. FANCM, RAD1, CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer. Cancer Genet. 235–236, 57–64 https://doi.org/10.1016/j.cancergen.2019.04.061 (2019).
Brosnan-Cashman, J. A. et al. SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma. Mod. Pathol. 34, 1810–1819 https://doi.org/10.1038/s41379-021-00841-7 (2021).
Liu, H. et al. Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells. Neuro Oncol. 25, 1563–1575 https://doi.org/10.1093/neuonc/noad022 (2023).
Diplas, B. H. et al. The genomic landscape of TERT promoter wildtype–IDH wildtype glioblastoma. Nat. Commun. 9, 2087 https://doi.org/10.1038/s41467-018-04448-6 (2018).
Ballinger, M. L. et al. Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science 379, 253–260 https://doi.org/10.1126/science.abj4784 (2023).
Golubicki, M. et al. Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome. JCI Insight 5, e140698 https://doi.org/10.1172/jci.insight.140698 (2020).
Goldberg, Y. et al. MCM9 is associated with germline predisposition to early-onset cancer—clinical evidence. NPJ Genom. Med. 6, 78 https://doi.org/10.1038/s41525-021-00242-4 (2021).
Choi, M., Kipps, T. & Kurzrock, R. ATM mutations in cancer: therapeutic implications. Mol. Cancer Ther. 15, 1781–1791 https://doi.org/10.1158/1535-7163.MCT-15-0945 (2016).
Aditi et al. Genome instability independent of type I interferon signaling drives neuropathology caused by impaired ribonucleotide excision repair. Neuron 109, 3962–3979 https://doi.org/10.1016/j.neuron.2021.09.040 (2021).
Zimmermann, M. et al. CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. Nature 559, 285–289 https://doi.org/10.1038/s41586-018-0291-z (2018).
Yang, X. et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 8, 659–661 https://doi.org/10.1038/nmeth.1638 (2011).
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 https://doi.org/10.1126/science.1231143 (2013).
Hart, T., Brown, K. R., Sircoulomb, F., Rottapel, R. & Moffat, J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol. 10, 733 https://doi.org/10.15252/msb.20145216 (2014).
Hart, T. et al. Evaluation and design of genome-wide CRISPR/SpCas9 knockout screens. G3 (Bethesda) 7, 2719–2727 https://doi.org/10.1534/g3.117.041277 (2017).
Ng, P. C. & Henikoff, S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812–3814 https://doi.org/10.1093/nar/gkg509 (2003).
Campello, R. J. G. B., Moulavi, D., Zimek, A. & Sander, J. Hierarchical density estimates for data clustering, visualization, and outlier detection. ACM Trans. Knowl. Discov. Data 10, 1–51 https://doi.org/10.1145/2733381 (2015).
Steinegger, M. & Soding, J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 35, 1026–1028 https://doi.org/10.1038/nbt.3988 (2017).
Mirdita, M. et al. Uniclust databases of clustered and deeply annotated protein sequences and alignments. Nucleic Acids Res. 45, D170–D176 https://doi.org/10.1093/nar/gkw1081 (2017).
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 https://doi.org/10.1093/molbev/mst010 (2013).
Bryant, P., Pozzati, G. & Elofsson, A. Improved prediction of protein–protein interactions using AlphaFold2. Nat. Commun. 13, 1265 https://doi.org/10.1038/s41467-022-28865-w (2022).
Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679–682 https://doi.org/10.1038/s41592-022-01488-1 (2022).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 https://doi.org/10.1038/s41586-021-03819-2 (2021).
Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. Preprint at bioRxiv https://doi.org/10.1101/2021.10.04.463034 (2022).
Oughtred, R. et al. The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 30, 187–200 https://doi.org/10.1002/pro.3978 (2021).
Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 https://doi.org/10.1016/j.cell.2015.11.054 (2015).
Richardson, C. D. et al. CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway. Nat. Genet. 50, 1132–1139 https://doi.org/10.1038/s41588-018-0174-0 (2018).
Neelsen, K. J., Chaudhuri, A. R., Follonier, C., Herrador, R. & Lopes, M. Visualization and interpretation of eukaryotic DNA replication intermediates in vivo by electron microscopy. Methods Mol. Biol. 1094, 177–208 https://doi.org/10.1007/978-1-62703-706-8_15 (2014).
Wong, N., John, S., Nussenzweig, A. & Canela, A. END-seq: an unbiased, high-resolution, and genome-wide approach to map DNA double-strand breaks and resection in human cells. Methods Mol. Biol. 2153, 9–31 https://doi.org/10.1007/978-1-0716-0644-5_2 (2021).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 https://doi.org/10.1186/gb-2009-10-3-r25 (2009).
Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165 https://doi.org/10.1093/nar/gkw257 (2016).
来源:Nature Biotechnology · nature.com